Sankala Group’s Abbott ABT Stock Holding History

Sankala Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244	Hold	2	–	–	﹤0.01%	545
2025 Q4	$271	Buy	+2	New	+$255	﹤0.01%	560

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sankala Group's ABT Position: Q1 2026 in Review

Sankala Group held its Abbott (ABT) position steady in Q1 2026 at 2 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Sankala Group first reported a position in ABT in Q4 2025 and has held it in 2 quarters since. The position peaked at $271 in Q4 2025. 3,098 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Sankala Group held 2 shares of Abbott worth $244 as of Q1 2026.
Sankala Group left its Abbott share count unchanged in Q1 2026.
Abbott made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #545 holding.
Sankala Group first reported a position in Abbott in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Abbott position peaked at $271 in Q4 2025.
3,098 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.